Bromocriptine generally refers to bromocriptine mesylate tablets, which can treat non-prolactin-dependent infertility and prolactin-dependent infertility. In addition, bromocriptine mesylate tablets can also treat conditions such as hyperprolactinoma and acromegaly. Bromocriptine Mesylate Tablets can be used in the treatment of non-prolactin-dependent infertility, such as polycystic ovary syndrome, or in combination with estrogen such as clomiphene to treat anovulation. In addition, bromocriptine mesylate tablets can also be used to treat prolactin-dependent infertility, which is often accompanied by normal or high prolactin. In addition to treating some infertility, bromocriptine mesylate tablets can also be used in the treatment of hyperprolactinoma, acromegaly, prolactin-dependent menstrual cycle disorders, benign breast nodules, premenstrual syndrome, Parkinson’s disease and so on. It is recommended that patients can use bromocriptine mesylate tablets under the guidance of a doctor, and it is recommended that those who are allergic to bromoergot cyclic peptide as well as the ingredients of bromocriptine mesylate tablets should be prohibited from using the drug, and bromocriptine mesylate tablets should not be used if the patient has serious mental illness or valvular disease. In addition, some patients with bromocriptine mesylate tablets may experience nausea and vomiting, dizziness, headache and other adverse reactions.